U.T. MD Anderson Cancer Center — Houston, Texas

U.T. MD Anderson Cancer Center is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

U.T. MD Anderson Cancer Center has participated in 8 clinical trials with 5 currently active.

Therapeutic areas: Prostate Cancer, HER2 Positive Breast Cancer, Early Breast Cancer.

Sponsors: University of British Columbia, Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for U.T. MD Anderson Cancer Center?

U.T. MD Anderson Cancer Center has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has U.T. MD Anderson Cancer Center conducted?

U.T. MD Anderson Cancer Center has 8 clinical trials on record, with 5 currently active. Their work covers Prostate Cancer, HER2 Positive Breast Cancer, Early Breast Cancer.

Is U.T. MD Anderson Cancer Center accredited by Crixeo Health?

Yes — U.T. MD Anderson Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about U.T. MD Anderson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.